EDIT vs KHC · rev $32.3M vs P/E 12, $31.55B cap
Editas Medicine Inc (EDIT) versus Kraft Heinz Co (KHC) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Kraft Heinz Co (KHC) is a packaged foods company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
KHC does not have a complete income-statement cache yet.
EDIT currently screens at market cap $375.2M. KHC currently screens at market cap $31.55B and trailing P/E 12.2.
Not investment advice. Open the EDIT and KHC stock pages for the full models.
Not investment advice.